Goodwin Biotechnology, Inc. is a fully integrated cGMP contract manufacturing organization (CMO) of monoclonal antibodies and recombinant proteins for preclinical and Phase I/II/III clinical trials. With over 14 years experience as an independent contract manufacturer, GBI has worked with companies of all sizes from small university spin-offs to major research institutes, government agencies and large established biopharmaceutical companies.
Latest News
> April 2008 - Goodwin Biotechnology, Inc. Completes Major Expansion Project
> March 2008 - Q Therapeutics selects Goodwin Biotechnology for manufacturing of its IgM
> July 2007 - Goodwin Biotechnology and Menarini Announce the Successful Completion of
their Strategic US-Italian Cooperation to Fight Ovarian Cancer
Upcoming events and Appearances
To schedule an appointment with a GBI Representative at any of the following events, please contact:
David Fischer
Executive Vice President for Client Operations
Phone: 954.327.9613
Email: dfischer@goodwinbio.com
Join us at:
The 2008 BIO International Convention in San Diego
June 17 - 20, 2008
Convention Center
Booth 2432 in BioProcess Zone and Opposite the BioProcess Theatre
San Diego, CA
|
